Abeona Therapeutics
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $2,824 |
Gross Profit | 0 | -1,667 | -724 | 2,103 |
EBITDA | -28,445 | 10,145 | -29,901 | -15,761 |
EBIT | -29,167 | 8,478 | -30,625 | -16,482 |
Net Income | -30,269 | 7,406 | -31,578 | -16,591 |
Net Change In Cash | 0 | 0 | 0 | 2,824 |
Free Cash Flow | -12,638 | -13,395 | -15,263 | -9,272 |
Cash | 15,726 | 34,426 | 17,558 | 14,473 |
Basic Shares | 48,081 | 51,226 | 27,315 | 25,555 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $3,500 | $1,414 | $3,000 | $10,000 |
Gross Profit | 2,435 | 964 | -1,464 | -20,139 |
EBITDA | -50,572 | -34,383 | -76,802 | -74,518 |
EBIT | -53,770 | -38,960 | -81,266 | -80,119 |
Net Income | -54,188 | -31,809 | -88,606 | -88,349 |
Net Change In Cash | 3,500 | 1,414 | 3,000 | 10,000 |
Cost of Revenue | -116,797 | |||
Free Cash Flow | -37,340 | -43,613 | -69,816 | -36,355 |
Cash | 14,473 | 14,217 | 32,938 | 12,596 |
Basic Shares | 21,380 | 7,861 | 3,937 | 3,706 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.31 |
2024-06-30 | $0.19 |
2024-03-31 | -$1.16 |
2023-12-31 | -$0.77 |
